Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2022 Jul 26;13:338. doi: 10.1186/s13287-022-03086-6

Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury

Charlotte Sarre 1,2,#, Rafael Contreras-Lopez 1,2,#, Nitirut Nernpermpisooth 3, Christian Barrere 1, Sarah Bahraoui 2, Claudia Terraza 2, Gautier Tejedor 2, Anne Vincent 1, Patricia Luz-Crawford 4,5, Kantapich Kongpol 1,6, Sarawut Kumphune 9, Christophe Piot 1,7, Joel Nargeot 1, Christian Jorgensen 2,8, Farida Djouad 2,, Stéphanie Barrere-Lemaire 1,
PMCID: PMC9327276  PMID: 35883123

Correction to: Stem Cell Research & Therapy (2022) 13:167 10.1186/s13287-022-02840-0

The original article contained errors in the attribution of affiliations which have since been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Charlotte Sarre and Rafael Contreras-Lopez have contributed equally to this work

Contributor Information

Farida Djouad, Email: farida.djouad@inserm.fr.

Stéphanie Barrere-Lemaire, Email: Stephanie.barrere@igf.cnrs.fr.


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES